CIRCULOGENE
Patients Deserve the Best
Liquid Biopsy Center
CIRCULOGENE is a molecular diagnostics company specializing in liquid biopsy technologies to detect clinically significant tumor DNA and RNA alterations. Since its inception in 2015, the company has provided innovative, non-invasive testing solutions to over 25,000 cancer patients, aiding oncologists in personalizing and monitoring treatment plans for improved patient outcomes.
Headquartered in Birmingham, Alabama, with laboratories in Pensacola and West Palm Beach, Florida, CIRCULOGENE combines patented methodologies with advanced technologies to offer a comprehensive suite of testing services.
Featured Products
SDV Medical offers a variety of cutting-edge CIRCULOGENE products in our catalog. Our flagship offerings from CIRCULOGENE are:
ImmunoClear
ImmunoClear is the only liquid biopsy method that includes plasma cell-free RNA (cfRNA) PD-L1 testing. PD-L1 expression has been correlated with clinical effectiveness and improved survival rates when treated with immunotherapy. ImmunoClear has been demonstrated to be predictive of significant survival benefits of immunotherapy treatment over chemotherapy in advanced non-small cell lung cancer (NSCLC) patients.
MSI Complete
MSI Complete utilizes advanced Microsatellite Instability (MSI) technology to provide physicians with a superior, functional, molecular measurement of the level of DNA mismatch repair deficiency demonstrated within their patient's tumor. MSI-High (MSI-H) status could be an indication of immunotherapy response in colorectal cancer. This test aids in identifying patients who may benefit from specific immunotherapies.
TumorClear
TumorClear is CIRCULOGENE's Next-Generation Sequencing (NGS) panel that includes National Comprehensive Cancer Network (NCCN) guideline markers and expert-recommended actionable mutations. It provides oncologists with a detailed molecular profile to guide targeted treatment decisions.
Proud Partners
Liquid Biopsy Results in Faster Time To Treatment
SDV Medical is a proud partner and distributor of CIRCULOGENE's innovative Liquid biopsy systems because we believe in making a difference for patients and healthcare providers alike. Our values align with CIRCULOGENE’s commitment to advancing cancer care, particularly in the context of veteran health at Veterans Association Hospitals. CIRCULOGENE's commitment to innovation and patient care is evident in its comprehensive testing solutions, providing actionable insights to personalize and improve cancer treatment strategies
SDV Medical's expertise is in supporting VA and DOD hospitals acquire state-of-the-art products like those from CIRCULOGENE. Learn more about how we make this possible.
Featured Resources
A Breakthrough in Cancer Detection and Treatment
Circulogene now offers a groundbreaking liquid biopsy blood test that transforms cancer detection and treatment. This non-invasive test analyzes circulating tumor DNA (ctDNA) from a simple blood draw, enabling earlier diagnosis, personalized therapies, and real-time monitoring of disease. Unlike traditional surgical biopsies, Circulogene’s rapid and accurate genetic profiling delivers results within days, guiding oncologists in making targeted, effective treatment decisions. Key benefits include quicker results, reduced patient discomfort, and enhanced treatment precision.
Programmatic Upstream Liquid Biopsy Molecular Testing in Lung Cancer
Advances have facilitated an ease of molecular testing in lung cancer.
Programmatic Upstream Liquid Biopsy Molecular Testing in GI Cancers
Liquid biopsy with plasma NGS is revolutionizing GI cancer treatment by rapidly detecting key tumor mutations through circulating tumor DNA.
Media Gallery
Knowledge is Power
Greatly enhance your ability to make sound purchase decision on these complex and complicated products. Check out our FREE resource center! Built for you to make the BEST decisions for the Veterans you serve.